He is a board certified physician and graduate of Harvard University and Harvard Medical School. Dr. Bueno has conducted extensive research on molecular diagnosis and mechanisms of carcinogenesis in malignant pleural mesothelioma. His clinical interests include mesothelioma, lung cancer, esophageal cancer, benign esophageal disorders, tracheal surgery, thymomas and minimally invasive surgery. Dr. Bueno's laboratory research objectives primarily concentrate on mesothelioma and its characteristics at the molecular level in order to design novel diagnostic and therapeutic modalities. About the Executive Advisory Board